R&D/ Views & Analysis/ Views and analysis Surviving as a rare disease biotech during COVID-19 George Underwood biotechs, coronavirus, COVID-19, Cure Rare Disease, Rare diseases 0 Comment With trial delays, social distancing, and falls in charitable funding, the coronavirus pandemic presents some serious challenges for Share X Surviving as a rare disease biotech during COVID-19 https://pharmaphorum.com/r-d/views-analysis-r-d/surviving-as-a-rare-disease-biotech-during-covid-19/
biotechs, coronavirus, COVID-19, Cure Rare Disease, Rare diseases
0 Comment
